Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer.

Abstract

This study aimed to evaluate the feasibility and efficacy of neoadjuvant chemoradiotherapy intensified with irinotecan in patients with locally advanced rectal cancer. Eligible patients had nonmetastatic disease at a locally advanced stage that made R0 resection and sphincter preservation uncertain. They received preoperative radiation over 6 weeks to 45 Gy and boost of 5.4 Gy and concurrent continuous infusion 5-fluorouracil 250 mg m(-2) day(-1) and weekly irinotecan 40 mg m(-2). In all, 37 patients entered the study. T stage at baseline as determined by ultrasound was T2/T3/T4 in 2/19/16 patients; 31 patients had lymph node involvement. The predominant toxicity was diarrhoea (grade 3/4 in 10/2 patients). Haematologic toxicity and surgical complications were moderate. Among 36 patients undergoing surgery, 32 (89%) had R0 resection and 23 (64%) sphincter preservation. Pathologic complete response (pCR) was achieved in eight (22%) of 36 patients, and 10 patients (28%) had only microscopic residual disease. At 4 years, overall survival was 66%, disease-free survival 73%, local relapse rate 7%, and distant failure rate 24%. Extent of resection and postoperative nodal status were significant predictors of overall and disease-free survival. Intensified neoadjuvant chemoradiotherapy with irinotecan can be safely administered and results in a high pCR rate.

• Authors: G Klautke, P Feyerherd, K Ludwig, F Prall, T Foitzik, R Fietkau
• Journal: British journal of cancer (Br J Cancer) Vol. 92 Issue 7 Pg. 1215-20 (Apr 11 2005) ISSN: 0007-0920 [Print] England
• PMID: 15785742 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Irinotecan
• Fluorouracil
• Camptothecin

Topics

• Adenocarcinoma (drug therapy, pathology, radiotherapy, surgery)
• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Camptothecin (administration & dosage, analogs & derivatives)
• Combined Modality Therapy
• Dose Fractionation, Radiation
• Female
• Fluorouracil (administration & dosage)
• Humans
• Irinotecan
• Male
• Middle Aged
• Neoadjuvant Therapy
• Rectal Neoplasms (drug therapy, pathology, radiotherapy, surgery)
• Survival Analysis
• Treatment Outcome